Kailera launches with $400M for next-generation weight-loss drugs

The latest stories trending on MedCity News.

Editor's Pick

Top Story Metabolic Meds Biotech Kailera Launches With $400M for Next-Generation Weight-Loss Drugs Kailera Therapeutics licensed its portfolio of metabolic disorder drugs from Hengrui. The most advanced program has results from a Phase 2 test in China suggesting it could be competitive with other medications that target the GLP-1 and GIP receptors to trigger weight loss. Sponsored Embracing Biosimilars to Lower Costs & Foster Innovation Presented by Evernorth Health, Inc. PBMs like Express Scripts are embracing biosimilar competition to provide cost savings today and access to innovative medicines in the future. Read more about our longstanding commitment to driving cost savings. Learn more.

Featured News

Lyra Health Expands Substance Use Disorder Support Mental health company Lyra Health is now offering services for people struggling with cannabis, stimulants, opioids and nicotine. Nym Rakes In $47M for Autonomous Coding Engine  Autonomous coding startup Nym raised $47 million. The New York City-based company has 21 provider customers, including Geisinger and Ochsner Health. Staff Safety is Key to Sustaining Home Health Growth Innovative approaches to home care will only be successful if organizations can ensure the safety of the professionals who enter patient homes. To do that, they'll need to embrace new technologies that support in-home caregivers in real-time, and implement new protocols that ensure they are provided with the security and comfort they deserve.  Patient Safety Structural Measure Marks Progress Towards Safer and Compassionate Care CMS recently finalized the Patient Safety Structural Measure, which sets forth a broad roadmap for the implementation of a culture of safety, learning, transparency and accountability within hospitals and health systems nationwide — enabling and encouraging significant progress towards safer care and improved support for healthcare workers.

Resources

MedCity Pivot Podcast: How AI Can Help in Cancer Dr. Timothy Showalter talks about how AI can be a powerful force in recommending treatment for cancer patients. He is Artera's chief medical officer and the company has built a digital pathology tool for prostate cancer patients. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe